Article
K45R variant of squalene synthase increases total cholesterol levels in two study samples from a French Canadian population.
Human mutation - 1 May 2008
Do Ron, Paré Guillaume, Montpetit Alexandre, Hudson Thomas J, Gaudet Daniel, Engert James C
Abstract excerpt
Squalene synthase is an important component of the cholesterol biosynthetic pathway, and inhibitors of this enzyme have been shown to lower plasma cholesterol levels. Previously, we sequenced the squalene synthase gene, FDFT1 (farnesyl-diphosphate farnesyltransferase), and identified several SNPs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
